- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 727143, 8 pages
Aldose Reductase Inhibitory Activity of Compounds from Zea mays L.
1Department of Food Science and Nutrition, Hallym University, Chuncheon 200-702, Republic of Korea
2Institute of Natural Medicine, Hallym University, Chuncheon 200-702, Republic of Korea
3Department of Biochemistry, College of Medicine, Hallym University, Chuncheon 200-702, Republic of Korea
Received 9 November 2012; Revised 11 January 2013; Accepted 11 January 2013
Academic Editor: Elvira Gonzalez De Mejia
Copyright © 2013 Tae Hyeon Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Aldose reductase (AR) inhibitors have a considerable therapeutic potential against diabetes complications and do not increase the risk of hypoglycemia. Through bioassay-guided fractionation of an EtOH extract of the kernel from purple corn (Zea mays L.), 7 nonanthocyanin phenolic compounds (compound 1–7) and 5 anthocyanins (compound 8–12) were isolated. These compounds were investigated by rat lens aldose reductase (RLAR) inhibitory assays. Kinetic analyses of recombinant human aldose reductase (rhAR) were performed, and intracellular galactitol levels were measured. Hirsutrin, one of 12 isolated compounds, showed the most potent RLAR inhibitory activity (IC50, 4.78 μM). In the kinetic analyses using Lineweaver-Burk plots of 1/velocity and 1/substrate concentration, hirsutrin showed competitive inhibition against rhAR. Furthermore, hirsutrin inhibited galactitol formation in rat lens and erythrocytes sample incubated with a high concentration of galactose; this finding indicates that hirsutrin may effectively prevent osmotic stress in hyperglycemia. Therefore, hirsutrin derived from Zea mays L. may be a potential therapeutic agent against diabetes complications.
Trials on diabetes control and complications show that hyperglycemia is a key factor in the development of diabetic complications. Diabetic complications occur in many tissues and affect various sensory organs, the nervous system, circulation, and renal excretion [1–3].
Diabetic complications can arise from increased flux through the polyol pathway. Aldose reductase (AR) (alditol: NAD (P)+ 1-oxidoreductase, EC 220.127.116.11) is a reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) specific aldo-keto oxidoreductase used to catalyze the conversion of glucose to galactitol in the polyol pathway, which is the alternate route for the metabolism of a small amount of nonphosphorylated glucose . Because polyols such as galactitol do not readily move across the cell membranes, they can cause severe osmotic stress, leading to cell swelling and damage.
This pathway plays an important role in the etiology of complications of diabetes, such as neuropathy, cataract formation, nephropathy, and retinopathy. Therefore, inhibitors of AR may have the potential to treat long-term diabetic complications .
Although the development and progression of diabetic complications can be prevented by controlling blood glucose, it is difficult to regulate normal blood glucose in a diabetic patient. Therefore, AR inhibition has been recognized as an important strategy in the prevention and attenuation of long-term diabetic complications; further, AR inhibitors are being studied as potential therapeutics against diabetic complications [5, 6].
Purple corn (Zea mays L.) has been cultivated for centuries in the Andean region. Peruvian people consume a typical drink made from purple corn called “chicha morada,” a folk medicine that is believed to improve health. Purple corn is an important source of anthocyanins, which have potential applications as natural food colorants and antioxidants . The flavonoid pigments present in a wide range of plant products are considered to have antioxidant effects that inhibit cell mutation and reduce chemically induced colorectal carcinogenesis, but they may also prevent diabetes [8–10].
Beneficial health-related effects of other nonanthocyanin phenolic compounds (dehydrodieugenol, trans-coniferyl aldehyde, trans-coniferyl alcohol, condensed tannin, catechin, p-hydroxybenzoic, protocatechuic, p-coumaric, syringic, caffeic, and ferulic acids) have also been extensively reported including antioxidant [11–13], antimutagenic [14, 15], anticarcinogenic activity [16–18], and other biological properties.
In general, corn is considered an important crop worldwide. There have been some studies in the identification and quantification of phenolic compounds from yellow corn including p-hydroxybenzoic, protocatechuic, p-coumaric, and ferulic acids [11–13]. However, the bioactivity of nonanthocyanin phenolic compounds present in purple corn has not been reported to our knowledge.
In this paper, we report the inhibition of rat lens aldose reductase (RLAR) by an ethanol extract of the kernel of Zea mays L. (purple corn), the isolation of active compounds, and their structure-activity relationships. We also investigated the effects of these compounds on galactitol accumulation in rat lens and erythrocytes.
2. Materials and Methods
1H- and 13C-NMR spectra were recorded with a Bruker Avance 600 MHz NMR spectrometer (karlsruhe, Germany) operating at 600 and 150 MHz, respectively. The first grade solvents were used for extraction, fractionation, and column chromatography. RP C-18 (40–75 mesh, Nacalai tesque, Japan) was used as the column packing material. DL-Glyceraldehyde, D-glucose, bovine serum albumin (BSA), nicotinamide adenine dinucleotide phosphate (NADPH), and quercetin were purchased from Sigma Chemical (St. Louis, MO, USA). Recombinant human aldose reductase (rhAR) was purchased from Wako Pure Chemical Industries (Osaka, Japan). All tested compounds were isolated from the kernel of purple corn (Session 2.3.), and the structures of the compounds were elucidated using mass spectrometry and NMR spectroscopy: protocatechuic acid (compound no. 1, MF: C7H6O4, Mw: 154.12 g/mol, 98.6% in HPLC), vanillic acid (2, MF: C8H8O4, Mw: 168.15, 94.4%), 2,4,6-trihydroxybenzoic acid (3, MF: C7H6O5, Mw: 170.12, 97.8%), p-hydroxycinnamic acid (4, MF: C9H8O3, Mw: 164.16, 96.6%), ferulic acid (5, MF: C10H10O4, Mw: 194.18, 97.1%), hirsutrin (6, MF: C21H20O12, Mw: 464.10, 93.9%), 3′-methoxyhirsutrin (7, MF: C22H22O13, Mw: 494.10, 96.7%), cyanidin-3-glucoside (8, MF: C21H22O11, Mw: 448.41, 99.6%), pelargonidin-3-glucoside (9, MF: C21H20O13, Mw: 432.18, 98.4%), peonidin-3-glucoside (10, MF: C22H24O11, Mw: 464.15, 98.2%), cyanidin 3-(6′′-malonylglucoside) (11, MF: C24H23O14, Mw: 535.43, 98.9%), and pelargonidin 3-(6′′-malonylglucoside) (12, MF: C24H23O13, Mw: 519.0, 96.2%).
2.2. Plant Materials
Purple corn extract in a powdered form was provided by Brilliant Project Int’l Co., Ltd. (Seoul, Korea). The powder was transferred into a glass open column (1.0 × 900 mm i.d.), filled with Diaion HP-20 resin (Mitsubishi, Japan), and eluted with water to remove sugar and impurities, followed by ethanol to obtain the purple corn polyphenol extracts (PCPEs). The obtained PCPEs solution was evaporated and freeze-dried, and it was maintained at −20°C for further experiments.
2.3. Isolation and Identification
For solvent fractionation, PCPE (60 g) was suspended in water and then partitioned sequentially with n-hexane (Hex), methylene chloride (MC), ethyl acetate (EtOAc), and n-butanol (n-BuOH), leaving a residual aqueous fraction (Aq). Each fraction was then evaporated in vacuo to yield the Hex (0.33 g, 0.55%), MC (0.65 g, 1.08%), EtOAc (5.57 g, 9.28%), n-BuOH (26.44 g, 44.07%), and Aq (22.98 g, 38.30%) fractions.
The EtOAc fraction (5.57 g) was subjected to C-18 gel (Lichroprep RP-18 (40–63 μm); Merck, Darmstadt, Germany) column chromatography, eluted with water and increasing methanol concentration in an H2O-MeOH gradient system (95 : 5 → 50 : 50, v/v) to yield 93 subfractions as eluting solvents for the isolation of compounds 1 (5.1 mg), 2 (12.6 mg), 3 (6.5 mg), 4 (15.0 mg), 5 (5.5 mg), 6 (21.0 mg), and 7 (20.0 mg) (Figure 1).
Anthocyanins were isolated following a modified procedure of that described by Renault et al. . The n-BuOH fraction (500 mg) was subjected to high-speed countercurrent chromatography (HSCCC). The HSCCC system employed in the present study was a Model TBE-1000A HSCCC (Shanghai Tauto Biotechnique, Shanghai, China) with 3 multilayer coil columns connected in series and a 50-mL sample loop. The inner diameter of the PTFE tubing was 1.8 mm, and the total volume capacity was 1000 mL. The b-value of the preparative column varied from 0.42 at the internal layer to 0.63 at the external layer. The rotation speed of the apparatus was regulated, using a speed controller, to be in the range from 0 to 600 rpm. The HSCCC system was equipped with a Model Hitachi L-6200 intelligent pump (Hitachi, Tokyo, Japan), Model TOPAZ dual UV monitor operating at 520 nm, and Model ECOMAC-ECOM Acquisition and Control (version 0.97). The upper phase, consisting of a mixture of n-BuOH : acetic acid : water (4 : 1 : 5, v/v/v), was used as the stationary phase, while the lower phase was used as the mobile phase. The mobile phase had a flow rate of 2.5 mL/min; centrifugation was carried out at 400 rpm. Ten milliliters of each fraction was collected. Compounds 8 (6.8 mg), 9 (1.7 mg), 10 (1.7 mg), 11 (7.6 mg), and 12 (5.4 mg) were isolated (Figure 1) and identified by LC-MS/MS. These compounds were identified by comparing their NMR data with those in the literature and/or by directly comparing with their authentic samples. Their chemical structures are shown in Figure 2.
2.4. Measurement of RLAR Activity
RLAR activity was assayed according to the methods described by Dufrane et al. . Rat lenses were removed from Sprague-Dawley rats weighting 250–280 g and frozen until required. The rat lens homogenate was prepared according to the method of Hayman and Kinoshita with some modifications [21–23]. A partially purified enzyme with a specific activity of 6.5 U/mg was routinely used to test the enzyme inhibitions. The partially purified material was separated into 1.0 mL aliquots and stored at −40°C. RLAR activity was assayed spectrophotometrically by measuring the decrease in absorption of NADPH at 340 nm over a 4-minute period with DL-glyceraldehyde as a substrate. Each 1.0 mL cuvette contained equal units of enzyme, 0.05 M sodium phosphate buffer (pH 6.2), and 0.3 mM NADPH with or without 10 mM substrate and inhibitor. For inhibition studies, concentrated stocks of AR inhibitors prepared in DMSO were used, and the final concentration of DMSO was not more than 1%. The concentration of inhibitors giving 50% inhibition of enzyme activity (IC50) was calculated from least-squares regression line of logarithmic concentrations plotted against the residual activity.
2.5. Kinetics of rhAR by Active Compounds
Reaction mixtures consisted of 0.1 M potassium phosphate, 0.16 mM NADPH, and 2 mM of rhAR with varied concentrations of substrate DL-glyceraldehyde and AR inhibitor in a total volume of 200 μL. Concentrations were ranged from 0.1 to 1.0 mM for DL-glyceraldehyde. rhAR activity was assayed spectrophotometrically by measuring the decrease in absorption of NADPH at 340 nm after substrate addition using Biotek Power Wave XS spectrophotometer (Biotek instruments, VT, USA) . and of rhAR were determined with varying concentrations of DL-glyceraldehyde as a substrate in the absence and presence of different concentrations of inhibitor by Lineweaver-Burk double reciprocal plots. Inhibitory constant () was derived by plotting slopes obtained from Lineweaver-Burk plots versus inhibitors concentration.
2.6. Lens Culture and Intracellular Galactitol Measurement
Lenses isolated from 10-week-old male rats were cultured for 6 d in TC-199 medium that contained 15% fetal bovine serum 100 U/mL penicillin and 0.1 mg/mL streptomycin under sterile conditions in an atmosphere of 5% CO2 and 95% air at 37°C. Samples were dissolved in DMSO. The lenses were divided into 3 groups and cultured in medium containing 5 mM glucose, 30 mM galactose and quercetin (positive control), hirsutrin, or 3′-methoxyhirsutrin. Each lens was placed in well containing 1.0 mL of medium. Lenses from each group were minced in 150 μL of phosphate-buffered saline on ice, homogenized by sonication, and centrifuged at 22.000 g for 10 min at 4°C. The supernatant was filtered through a membrane filter (Ultrafree-MC, nominal molecular weight limit 10,000; Millipore, Bedford, MA, USA) to remove proteins . HPLC analysis for sugar alcohol in lens was performed with this filtrate after being benzoylated .
2.7. Blood Culture and Intracellular Galactitol Measurement
Blood sample was collected in heparin-containing polypropylene tube from 10-week-old male rats. For sugar and sugar alcohol analysis, erythrocytes from heparinized blood were separated from the plasma and buffy coat by centrifuging at 2000 ×g for 10 min. The cells were washed thrice with normal saline (0.9% NaCl) at 4°C. In the final washing, the cells were centrifuged at 2000 ×g for 10 min to obtain a consistently packed cell preparation. The packed cells (1 mL) were then incubated in a Krebs-Ringer bicarbonate buffer (pH 7.4) containing 30 mM galactose in the presence or absence of samples at 37°C in 5% CO2 for 3 h. The erythrocytes were washed with cold saline by centrifuging at 2000 ×g for 10 min, precipitated by adding 6% of cold perchloric acid (3 mL), and centrifuged again at 2000 ×g for 10 min. The supernatant was neutralized with 2.5 M K2CO3 at 4°C and used for galactitol determination . HPLC analysis for sugar and sugar alcohol in blood was performed with this supernatant of red blood cell homogenate after being benzoylated .
3. Results and Discussion
The current study aimed to identify potential AR inhibitors from Zea mays L. that would be useful in the treatment of diabetic complications. To identify the active compounds from Zea mays L., the extract was divided into 5 systematic fractions, which were then tested for RLAR inhibitory activity using DL-glyceraldehyde as a substrate (Table 1). Of these fractions, the ethyl acetate (EtOAc) fraction was found to exhibit the strongest RLAR inhibitory activity with a mean IC50 value of 2.06 μg/mL, whereas the positive control quercetin showed an IC50 value of 2.34 μg/mL. This suggested the presence of ARIs in the EtOAc soluble fraction, so we focused on isolating ARIs from this fraction.
We isolated pure compounds by subjecting the EtOAc fraction to repeated chromatography on the RP C-18 chromatography. The chemical structures of 7 isolated compounds were identified. Chemical structures were elucidated by chemical and spectral analysis as protocatechuic acid (1), vanillic acid (2), 2,4,6-trihydroxybenzoic acid (3), 4-hydroxycinnamic acid (4), ferulic acid (5), hirsutrin (6), and 3′-methoxyhirsutrin (7). The n-BuOH fraction was subjected to HSCCC separation and yielded 5 compounds. Their chemical structures were identified by LC-MS as cyanidin-3-glucoside (8), pelargonidin-3-glucoside (9), peonidin-3-glucoside (10), cyanidin-3-(6′′-malonylglucoside) (11), and pelargonidin-3-(6′′-malonylglucoside) (12). The chemical structures of anthocyanins isolated are shown in Figure 2.
The RLAR inhibitory activities of the 12 flavonoids isolated from the EtOAc and n-BuOH fractions of Zea mays L. are shown in Table 2. Of the compounds isolated from the n-BuOH fraction, cyanidin-3-(6′′-malonylglucoside) (11) showed RLAR inhibitory activity with an IC50 value of 11.74 μM. Compounds 8, 9, 10, and 12 did not RLAR inhibitory activity. Hirsutrin (6) and 3′-methoxyhirsutrin (7) showed a good activity with IC50 values of 4.78 μM and 5.67 μM, respectively (the IC50 value of the positive control, quercetin, was 6.92 μM).
Yawadio et al. isolated 2 anthocyanins (cyanidin-3-glucoside and peonidin-3-glucoside) and a phenolic compound (ferulic acid) from black and pigmented brown rice, and their complete structures were determined by spectroscopic analysis (NMR, and MALDI-TOF MS) . The aldose reductase inhibitory activity of isolated compounds from black and pigmented brown rices was in the following decreasing order: cyanidin-3-glucoside > quercetin > ferulic acid > peonidin-3-glucoside.
In the previous study, we postulated the following relationships of structure to the inhibitory activities of flavonoids: (1) the flavones and flavonols having the 7-hydroxyl; (2) flavones and flavonols with a catechol moiety at the B ring (the 3′,4′-dihydroxyl moiety) show stronger activity; (3) the 5-hydroxyl moiety does not affect the activity; (4) the 2-3-double bond enhances the activity than other flavonoids [9, 29–31].
In order to determine the type of inhibition activity on rhAR for compounds 6 and 7, a kinetic study was conducted using DL-glyceraldehyde as the substrate (concentration, 0.1–1.0 mM), with 3 different concentrations for each compound. The Lineweaver-Burk plots (1/velocity and 1/concentration) for compounds 6 and 7 are shown in Figure 3. As the concentration of the inhibitor compound 6 increases, steeper and steeper lines are obtained in a double-reciprocal plot. These lines were all intersecting at the same point on the -axis, 1/. The maximum velocity () of the reaction is unchanged, while (Michaelis-Menten constant) is decreased. The result indicated that the inhibition type of rhAR by compound 6 was competitive. Further, we have determined inhibitory constant () from secondary plots of Lineweaver-Burk plots, and of compound 6 for rhAR was found to be M. In case of compound 7, the slopes were found to be parallel. and were decreased with glyceraldehydes as substrates (Figure 3). The result indicated that the inhibition type of rhAR by compound 7 was uncompetitive, that is, this inhibitor could bind neither to the substrate-binding region nor to the NADPH-binding region of rhAR. As reported by Bohren and Grimshaw , although many ionic inhibitors bind to active site, still they show noncompetitive to uncompetitive pattern inhibition because under steady-state conditions most of the enzyme will be present as enzyme-nucleotide binary complex. Hence, compounds that selectively bind to the enzyme-nucleotide complex are more effective than those bind to free enzyme.
We also investigated the effect of flavonoids (6 and 7) isolated from Zea mays L. on the accumulation of galactitol in rat lens and erythrocytes. The primary cause of complications of diabetes is an elevated level of plasma glucose. The excess glucose causes flux through the polyol pathway, which results in a marked increase in AR activity and the accumulation of sorbitol, the polyol of glucose, in all tissues that do not require insulin for glucose uptake. There is a greater accumulation of polyol by the reduction of galactose than glucose owing to the higher affinity of aldose reductase for galactose than for glucose and the fact that there is no subsequent metabolism of galactitol . The effects of compounds 6 and 7 on galactitol accumulation in rat erythrocytes are shown in Table 3. Galactitol accumulation was 22-fold greater when cells were incubated in a high-galactose medium, compared with incubation in a galactose-free medium. Compounds 6 and 7 effectively inhibited galactitol accumulation in rat erythrocyte by almost 32.54% and 11.96% at 50 μg/mL, respectively. The positive control, quercetin, inhibited galactitol accumulation in rat erythrocytes by 30.48%, whereas a high-galactose culture medium reduced the galactitol level. The effects of compounds 6 and 7 on galactitol accumulation in rat lens are also shown in Table 3. Compound 6 (hirsutrin) effectively inhibited galactitol accumulation in rat lens by almost 33.78% at 5 μg/mL. Quercetin, the positive control, inhibited by 46.82%.
Finally, the study of the selectivity of isolated compounds on aldehyde reductase could help to elucidate whether or not they have some deleterious side effects on human body.
In this study, we discovered that phenolic compounds isolated from Zea mays L. inhibit RLAR. We also found that phenolic compounds significantly suppressed galactitol accumulation in rat lens and erythrocytes. These results indicated that RLAR inhibitors isolated from Zea mays L. are effective in either preventing or retarding complications associated with diabetes.
This work was supported by the Grant from the Ministry for Food, Agriculture, Forestry and Fisheries through Korea Institute of Planning and Evaluation for Technology of Food, Agriculture, Forestry and Fisheries 109163-3 and by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2012-008842 and 2012R1A6A1048184).
- J. V. Santiago, “Overview of the complications of diabetes,” Clinical Chemistry, vol. 32, no. 10, pp. 48–53, 1986.
- G. Dario, M. Raffaele, Q. Antonio et al., “Tolrestat for mild diabetic neuropathy: a 52-week, randomized, placebo-controlled trial,” Annals of Internal Medicine, vol. 118, no. 1, pp. 7–11, 1993.
- J. Pirart, “Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973,” Diabete et Metabolisme, vol. 3, no. 3, pp. 173–182, 1977.
- Y. N. Chihiro, “Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications,” Pharmacological Reviews, vol. 50, no. 1, pp. 21–33, 1998.
- D. R. Tomlinson, E. J. Stevens, and L. T. Diemel, “Aldose reductase inhibitors and their potential for the treatment of diabetic complications,” Trends in Pharmacological Sciences, vol. 15, no. 8, pp. 293–297, 1994.
- J. H. Kinoshita, “Mechanisms intiating cataract formation,” Investigative Ophthalmology and Visual Science, vol. 13, no. 10, pp. 713–724, 1974.
- T. Tsuda, F. Horio, K. Uchida, H. Aoki, and T. Osawa, “Dietary cyanidin 3-O-β-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice,” Journal of Nutrition, vol. 133, no. 7, pp. 2125–2130, 2003.
- S. D. Varma, I. Mikuni, and J. H. Kinoshita, “Flavonoids as inhibitors of lens aldose reductase,” Science, vol. 188, no. 4194, pp. 1215–1216, 1975.
- S. D. Varma and J. H. Kinoshita, “Inhibition of lens aldose reductase by flavonoids: their possible role in the prevention of diabetic cataracts,” Biochemical Pharmacology, vol. 25, no. 22, pp. 2505–2513, 1976.
- J. Okuda, I. Miwa, and K. Inagaki, “Inhibition of aldose reductases from rat and bovine lenses by flavonoids,” Biochemical Pharmacology, vol. 31, no. 23, pp. 3807–3822, 1982.
- K. K. Adom and R. H. Liu, “Antioxidant activity of grains,” Journal of Agricultural and Food Chemistry, vol. 50, no. 21, pp. 6182–6187, 2002.
- V. Dewanto, X. Wu, and R. H. Liu, “Processed sweet corn has higher antioxidant activity,” Journal of Agricultural and Food Chemistry, vol. 50, no. 17, pp. 4959–4964, 2002.
- M. E. Snook, N. W. Widstrom, B. R. Wiseman, P. F. Byrne, J. S. Harwood, and C. E. Costello, “New C-4”-hydroxy derivatives of maysin and 3'-methoxymaysin isolated from corn silks (Zea mays),” Journal of Agricultural and Food Chemistry, vol. 43, no. 10, pp. 2740–2745, 1995.
- M. Miyazawa and M. Hisama, “Antimutagenic activity of phenyl-propanoids from clove (Syzygium aromaticum),” Journal of Agricultural and Food Chemistry, vol. 51, no. 22, pp. 6413–6422, 2003.
- C. K. Wang and W. H. Lee, “Separation, characteristics, and biological activities of phenolics in areca fruit,” Journal of Agricultural and Food Chemistry, vol. 44, no. 8, pp. 2014–2019, 1996.
- L. R. Fergyson, “Role of plant polyphenols in genomic stability,” Mutation Research, vol. 475, no. 1-2, pp. 89–111, 2001.
- N. Katsube, K. Iwashita, T. Tsushida, K. Yamaki, and M. Kobori, “Induction of apoptosis in cancer cells by bilberry (Vaccinium myrtillus) and the anthocyanins,” Journal of Agricultural and Food Chemistry, vol. 51, no. 1, pp. 68–75, 2003.
- G. Loo, “Redox-sensitive mechanisms of phytochemical-mediated inhibition of cancer cell proliferation,” Journal of Nutritional Biochemistry, vol. 14, no. 2, pp. 64–73, 2003.
- J. H. Renault, P. Thépenier, M. Zèches-Hanrot et al., “Preparative separation of anthocyanins by gradient elution centrifugal partition chromatograghy,” Journal of Chromatography A, vol. 763, no. 1-2, pp. 345–352, 1997.
- S. P. Dufrane, W. J. Malaisse, and A. Sener, “A micromethod for the assay of aldose reductase, its application to pancreatic islets,” Biochemical Medicine, vol. 32, no. 1, pp. 99–105, 1984.
- S. Hayman and J. H. Kinoshita, “Isolation and properties of lens aldose reductase,” The Journal of Biological Chemistry, vol. 240, no. 2, pp. 877–882, 1965.
- Y. S. Lee, Y. H. Kang, J. Y. Jung et al., “Inhibitory constituents of aldose reductase in the fruiting body of Phellinus linteus,” Biological and Pharmaceutical Bulletin, vol. 31, no. 4, pp. 765–768, 2008.
- S. S. Lim, Y. J. Jung, S. K. Hyun, Y. S. Lee, and J. S. Choi, “Rat lens aldose reductase inhibitory constituents of Nelumbo nucifera stamens,” Phytotherapy Research, vol. 20, no. 10, pp. 825–830, 2006.
- S. Sato and P. F. Kador, “Inhibition of aldehyde reductase by aldose reductase inhibitors,” Biochemical Pharmacology, vol. 40, no. 5, pp. 1033–1042, 1990.
- I. Miwa, A. S. Chen, and T. Taguchi, “Glyceraldehyde is present in rat lens and its level is increased in diabetes mellitus,” Ophthalmic Research, vol. 41, no. 2, pp. 98–101, 2009.
- S. Kwang-Hyok, P. Ui-Nam, C. Sarkar, and R. Bhadra, “A sensitive assay of red blood cell sorbitol level by high performance liquid chromatography: potential for diagnostic evaluation of diabetes,” Clinica Chimica Acta, vol. 354, no. 1-2, pp. 41–47, 2005.
- R. Shinolara, Y. Ohta, M. Yamachi, and I. Iahiguro, “Improved fluorometric enzymatic sorbitol assay in human blood,” Clinica Chimica Acta, vol. 273, no. 2, pp. 171–184, 1998.
- R. Yawadio, S. Tanimori, and N. Morita, “Identification of phenolic compounds isolated from pigmented rices and their aldose reductase inhibitory activities,” Food Chemistry, vol. 101, no. 4, pp. 1616–1625, 2007.
- S. Milan, “Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract,” Interdisciplinary Toxicology, vol. 4, no. 2, pp. 69–77, 2011.
- S. de Pascual-Teresa, C. Santos-Buelga, and J. C. Rivas-Gonzalo, “LC-MS analysis of anthocyanins from purple corn cob,” Journal of the Science of Food and Agriculture, vol. 82, no. 9, pp. 1003–1006, 2002.
- M. Hisashi, M. Toshio, T. Iwao, and Y. Masayuki, “Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity,” Chemical and Pharmaceutical Bulletin, vol. 50, no. 6, pp. 788–795, 2002.
- K. M. Bohren and C. E. Grimshaw, “The sorbinil trap: a predicted dead-end complex confirms the mechanism of aldose reductase inhibition,” Biochemistry, vol. 39, no. 32, pp. 9967–9974, 2000.
- W. G. Robison Jr. and N. Laver, “Ocular lesions in animal models of human diabetes,” in Frontiers in Diabetes Research, Lessons From Animal Diabetes IV, E. Shafrir, Ed., pp. 145–163, Smith-Gordon, London, UK, 1993.